What Researchers Did
Researchers critically evaluated the evidence for several emerging pharmacological and other somatic interventions for posttraumatic stress disorder (PTSD) in adults.
What They Found
The evidence for most novel pharmacological and somatic treatments for PTSD was found to be preliminary and highly variable. However, data for specific treatments like transcranial magnetic stimulation showed encouraging results.
What This Means for Canadian Patients
Canadian patients with PTSD who have not responded to conventional treatments may eventually have more options, as research into novel therapies continues. However, most of these emerging treatments are still in early stages of investigation and are not yet widely available or recommended.
Canadian Relevance
This review did not include any specific Canadian data or research.
Study Limitations
A key limitation is that the evidence supporting most novel treatments for PTSD is currently preliminary and highly variable.